We are live on
!
Find out more
PTC
Philadelphia Trust Company Portfolio holdings
AUM
$1.42B
1-Year Est. Return
43.77%
This Fund
S&P 500
This Quarter
Est. Return
-2.49%
1 Year Est. Return
+43.77%
3 Year Est. Return
+141.5%
5 Year Est. Return
+176.17%
10 Year Est. Return
+554.31%
AUM
$1.17B
AUM Growth
-$195M
(-14%)
Cap. Flow
-$131M
Cap. Flow
% of AUM
-11.23%
Top 10 Holdings %
Top 10 Hldgs %
42.13%
Holding
252
New
8
Increased
16
Reduced
106
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Uber
UBER
|
+$17.1M |
| 2 |
Honeywell
HON
|
+$7.64M |
| 3 |
GTLS
Chart Industries
GTLS
|
+$4.6M |
| 4 |
EQT Corp
EQT
|
+$2.41M |
| 5 |
Graham Corp
GHM
|
+$2.27M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertiv
VRT
|
+$21.5M |
| 2 |
NVIDIA
NVDA
|
+$15.4M |
| 3 |
Adobe
ADBE
|
+$9.29M |
| 4 |
Caterpillar
CAT
|
+$8.17M |
| 5 |
Gilead Sciences
GILD
|
+$7.89M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.79% |
| 2 | Industrials | 14.22% |
| 3 | Healthcare | 13.19% |
| 4 | Financials | 11.99% |
| 5 | Communication Services | 6.76% |
Similar funds
CBA
BC
KC
EWS
SCM
NI
QC
IHG
Philadelphia Trust Company's Q1 2025 Portfolio in Review
As of Q1 2025, Philadelphia Trust Company held 252 positions worth $1.17B, down 14% from $1.36B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Philadelphia Trust Company withdrew a net $131M in Q1 2025, closing 10 positions and reducing 106 holdings. Its most notable exit was Gilead Sciences, an estimated $7.89M position sold in full.
By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 36% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, Philadelphia Trust Company opened a new position in Uber worth $17.3M.
- Philadelphia Trust Company's largest Q1 2025 buy was Uber: 237,212 shares worth $17.3M.
- Philadelphia Trust Company added most to Honeywell in Q1 2025, an estimated $7.64M increase.
- Philadelphia Trust Company's biggest Q1 2025 reduction was Vertiv, cutting an estimated $21.5M.
- Philadelphia Trust Company fully exited Gilead Sciences in Q1 2025, selling an estimated $7.89M.
- Philadelphia Trust Company's ten largest holdings make up 42% of its $1.17B portfolio in Q1 2025.
- Philadelphia Trust Company opened 8 new positions and closed 10 in Q1 2025.
- Philadelphia Trust Company's portfolio value fell 14% quarter-over-quarter to $1.17B.
Based on Philadelphia Trust Company's 13F filing for Q1 2025, filed 13 May 2025.